Format

Send to

Choose Destination
Cancer Cytopathol. 2016 Jan;124(1):66-7. doi: 10.1002/cncy.21622. Epub 2015 Sep 10.

Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.

Author information

1
Interinstitutional Epidemiology Unit, Azienda Unita Sanitaria Locale di Reggio Emilia, Reggio Emilia, Italy, Arcispedale S. Maria Nuova, National Institute for Research and Treatment, Reggio Emilia, Italy.
2
Center for Cancer Epidemiology and Prevention, AO City of Health and Science, Turin, Italy.
3
Karolinska Institute, Stockholm, Sweden.
4
Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
5
Belgian Cancer Center, Scientific Institute of Public Health, Brussels, Belgium.
6
S. C. Laboratory for the Prevention of Cancer, Institute for the Study and Prevention of Cancer, Florence, Italy.
7
Veneto Institute of Oncology, National Institute for Research and Treatment, Padua, Italy.
8
Cancer Epidemiology Research Program, Catalan Institute of Oncology, Barcelona, Spain.
9
Department of Obstetrics and Gynecology, Wolfsburg Hospital, Wolfsburg, Germany.
10
Institute of Microbiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
11
Regione Emilia-Romagna, Bologna, Italy.
PMID:
26356132
DOI:
10.1002/cncy.21622
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center